GE HealthCare Technologies Statistics
Share Statistics
GE HealthCare Technologies has 456.87M shares outstanding. The number of shares has increased by 0.31% in one year.
Shares Outstanding | 456.87M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.04% |
Owned by Institutions (%) | n/a |
Shares Floating | 442.47M |
Failed to Deliver (FTD) Shares | 85.10K |
FTD / Avg. Volume | 2.58% |
Short Selling Information
The latest short interest is 8.28M, so 1.81% of the outstanding shares have been sold short.
Short Interest | 8.28M |
Short % of Shares Out | 1.81% |
Short % of Float | 1.87% |
Short Ratio (days to cover) | 3.45 |
Valuation Ratios
The PE ratio is 22.44 and the forward PE ratio is 18.18. GE HealthCare Technologies 's PEG ratio is 0.39.
PE Ratio | 22.44 |
Forward PE | 18.18 |
PS Ratio | 1.8 |
Forward PS | 1.8 |
PB Ratio | 4.93 |
P/FCF Ratio | 20.53 |
PEG Ratio | 0.39 |
Enterprise Valuation
GE HealthCare Technologies Inc. has an Enterprise Value (EV) of 42.55B.
EV / Earnings | 27.14 |
EV / Sales | 2.18 |
EV / EBITDA | 11.99 |
EV / EBIT | 17.47 |
EV / FCF | 24.82 |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 1.32.
Current Ratio | 1.05 |
Quick Ratio | 0.83 |
Debt / Equity | 1.32 |
Total Debt / Capitalization | 56.97 |
Cash Flow / Debt | 0.22 |
Interest Coverage | 4.49 |
Financial Efficiency
Return on equity (ROE) is 0.22% and return on capital (ROIC) is 9.72%.
Return on Equity (ROE) | 0.22% |
Return on Assets (ROA) | 0.05% |
Return on Capital (ROIC) | 9.72% |
Revenue Per Employee | 383.37K |
Profits Per Employee | 30.75K |
Employee Count | 51.00K |
Asset Turnover | 0.6 |
Inventory Turnover | 5.93 |
Taxes
Income Tax | 743.00M |
Effective Tax Rate | 0.31 |
Stock Price Statistics
The stock price has increased by 7.96% in the last 52 weeks. The beta is 1.21, so GE HealthCare Technologies 's price volatility has been higher than the market average.
Beta | 1.21 |
52-Week Price Change | 7.96% |
50-Day Moving Average | 86.17 |
200-Day Moving Average | 84.56 |
Relative Strength Index (RSI) | 40.12 |
Average Volume (20 Days) | 3.30M |
Income Statement
In the last 12 months, GE HealthCare Technologies had revenue of $19.55B and earned $1.57B in profits. Earnings per share was $3.04.
Revenue | 19.55B |
Gross Profit | 7.92B |
Operating Income | 2.44B |
Net Income | 1.57B |
EBITDA | 3.55B |
EBIT | 2.44B |
Earnings Per Share (EPS) | 3.04 |
Balance Sheet
The company has $2.49B in cash and $9.86B in debt, giving a net cash position of -$7.37B.
Cash & Cash Equivalents | 2.49B |
Total Debt | 9.86B |
Net Cash | -7.37B |
Retained Earnings | 1.33B |
Total Assets | 33.85B |
Working Capital | 1.97B |
Cash Flow
In the last 12 months, operating cash flow was $2.10B and capital expenditures -$387.00M, giving a free cash flow of $1.71B.
Operating Cash Flow | 2.10B |
Capital Expenditures | -387.00M |
Free Cash Flow | 1.71B |
FCF Per Share | 3.77 |
Margins
Gross margin is 40.52%, with operating and profit margins of 12.45% and 8.02%.
Gross Margin | 40.52% |
Operating Margin | 12.45% |
Pretax Margin | 12.08% |
Profit Margin | 8.02% |
EBITDA Margin | 18.15% |
EBIT Margin | 12.45% |
FCF Margin | 8.77% |
Dividends & Yields
GEHC pays an annual dividend of $0.11, which amounts to a dividend yield of 0.13%.
Dividend Per Share | $0.11 |
Dividend Yield | 0.13% |
Dividend Growth (YoY) | 22.22% |
Payout Ratio | 3.01% |
Earnings Yield | 3.75% |
FCF Yield | 4.63% |
Analyst Forecast
The average price target for GEHC is $100, which is 23.5% higher than the current price. The consensus rating is "Buy".
Price Target | $100 |
Price Target Difference | 23.5% |
Analyst Consensus | Buy |
Analyst Count | 13 |
Scores
Altman Z-Score | 1.93 |
Piotroski F-Score | 6 |